Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 14.8
1.44 %
$ 937 M
Market Cap
-16.26
P/E
EOLS - LONG-TERM DEBT
Long-term Debt EOLS - Evolus, Inc.
125 M
LAST VALUE
30.52%
2 YEAR CAGR
49.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR